Zr-89 Cimzia

UCSF Suspends Phase 1 Clinical Trial for Zr-89 Cimzia PET Imaging in Rheumatoid Arthritis Due to Funding Lapse

The University of California, San Francisco (UCSF) has suspended its Phase 1 clinical trial (NCT03546335) for Zr-89 Cimzia PET imaging in rheumatoid arthritis, citing a lapse in study funding. This halt impacts the development of a novel diagnostic radiopharmaceutical, raising concerns for stakeholders in medical imaging, autoimmune disease diagnostics, and radiopharmaceutical supply chains regarding investment and pipeline stability.